ESC 365 - Fenofibrate modulates cardiac energy metabolism in moderate-severe aortic stenosis: a mechanistic double-blinded randomised controlled MR trial

ESC Professional Premium Access

Fenofibrate modulates cardiac energy metabolism in moderate-severe aortic stenosis: a mechanistic double-blinded randomised controlled MR trial

Session: Exploring valvular and congenital heart disease with cardiac magnetic resonance

Topic: Valvular Heart Disease

Speaker: Doctor S. Monga (Oxford, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Shveta Monga

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

0 follower

4 more presentations in this session

Severe aortic stenosis is associated with left atrial prothrombotic flow changes that persists despite successful aortic valve replacement

Speaker: Doctor M. Spartera (Oxford, GB)

Right atrial and ventricular function in risk stratification of patients with pulmonary artery hypertension

Speaker: Miss J. Guo (Sichuan, CN)

Impact of epicardial adipose tissue and atrial functional impairment in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

Speaker: Doctor J. Gronwald (Goettingen, DE)

LV reverse remodeling after SAVR in patients with severe symptomatic aortic stenosis: impact on the clinical outcome

Speaker: Doctor M. Lima (Lisbon, PT)

Access the full session

Exploring valvular and congenital heart disease with cardiac magnetic resonance

Speakers: Doctor S. Monga, Doctor M. Spartera, Miss J. Guo, Doctor J. Gronwald, Doctor M. Lima

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources